United Kingdom · Question · Written question
HL HL2935
Drugs
Introduced
1 September 2026
Last action
—
Status
Awaiting answer
Sponsors
—
Subjects
Discovery layer
Source updated
1 September 2026
Summary
To ask His Majesty's Government whether the next review of NHS England's commercial framework for new medicines will consult on changes to the process for securing indication-specific pricing agreements for multi-indication medicines.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.